Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Thematic Issue Proposal

Guest Editors who wish to submit an issue proposal to Current Cancer Drug Targets are requested to complete the following online form. The proposal of thematic issue will then be immediately forwarded to the Editor-in-Chief/Co-Editors/Executive Editor(s) of Current Cancer Drug Targets who will then inform Guest Editors with a decision about the submitted proposal.

Note: * Required fields

*Title of the proposed Thematic Issue:
*Guest Editor Name:
*Guest Editor Affiliation:
*Guest Editor's List of Publications (Last - 5 Years):
*Issue Description:
Proposal Keywords:
*Thematic Issue Type:
*Total Articles:
Tentative date for submission of ALL manuscripts:



Contact Information:

*Title:
*First Name:
*Last Name:
User Category:
*Address:
*City/Town:
*Country:
State/Province:
ZIP/Postal code:
*E-mail:
Phone:
Fax:

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75

Advertisement

CITATION BOOSTERNew Year Offer 2021

Related Journals

Related eBooks

eBooks Catalog